rHEALTH Nanostrips, Vitals Device, and Fluidics Module to Receive U.S. Patent Protection
CAMBRIDGE, Mass., May 21, 2019 — DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, today announced that three critical components of its diagnose yourself, anywhere™ technology platform have received patent approvals and Notices of Allowance from the U.S. Patent and Trademark Office (USPTO).
rHEALTH Nanostrips and their multiplexing method (“Multi-dye microparticles”) have received a USPTO Notice of Allowance.
The SKYE Sensor, described as a multi-channel vitals device, is now U.S. Patent No. 10,251,565.
The Fluidics Module, a core subsystem of the rHEALTH ONE, has been granted U.S. Patent No. 10,279,347.
“These recent USPTO recognitions further solidify our commitment to protecting breakthrough innovations that enable high-quality patient care anywhere, anytime,” said Dr. Eugene Chan, President and CEO.
Nanostrips allow extensive multiplexing of medically-relevant tests in a single, small blood sample, effectively miniaturizing traditional test strips so that tens of thousands of unique assays can be run in just one drop of blood.
The SKYE Sensor delivers continuous, comprehensive vital monitoring, including core body temperature measurements, while the Fluidics Module enhances the rHEALTH ONE translational research instrument, giving researchers flexibility, precision, and ease-of-use in laboratory and point-of-care settings.
About rHEALTH
rHEALTH is a digital health solutions company focused on integrated technologies that transform healthcare delivery. Its innovations include:
rHEALTH Diagnostic Platform – enabling multiple laboratory tests from a single small-volume blood sample.
SKYE Sensor – a wireless wearable providing comprehensive real-time vitals monitoring.
CHAS – a user-friendly mobile application.
For more information, visit www.rhealth.com.
About DNA Medicine Institute
DNA Medicine Institute (DMI) is a biomedical incubator dedicated to advancing patient care and tackling complex medical challenges through innovation. Its work is supported by NASA, NIH, and the Bill & Melinda Gates Foundation. DMI leverages expertise in interdisciplinary science and engineering to develop practical solutions to critical healthcare problems.
For more information, visit www.dnamedinstitute.com.